Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
Cattaneo C, Cancelli V, Imberti L, Dobbs K, Sottini A, Pagani C, Belotti A, Re A, Anastasia A, Quaresima V, Tucci A, Chiorini JA, Su HC, Cohen JI, Burbelo PD, Rossi G, Notarangelo LD. Cattaneo C, et al. Among authors: cancelli v. Blood Cancer J. 2021 Sep 14;11(9):151. doi: 10.1038/s41408-021-00546-9. Blood Cancer J. 2021. PMID: 34521813 Free PMC article.
Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
Belotti A, Ribolla R, Cancelli V, Villanacci A, Angelini V, Chiarini M, Giustini V, Facchetti GV, Roccaro AM, Ferrari S, Peli A, Bottelli C, Cattaneo C, Crippa C, Micilotta M, Frittoli B, Grazioli L, Rossi G, Tucci A. Belotti A, et al. Among authors: cancelli v. Cancer Med. 2021 Sep;10(17):5859-5865. doi: 10.1002/cam4.4136. Epub 2021 Jul 15. Cancer Med. 2021. PMID: 34263564 Free PMC article.
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Cancelli V, Elli EM, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Carli G, Cuevas B, Hernandez-Boluda JC, Abadia EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-Garcia N, Bellini M, Betti S, Harrison C, Rambaldi A, Vannucchi AM. Barbui T, et al. Among authors: cancelli v. Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3. Blood Cancer J. 2021. PMID: 33563901 Free PMC article.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cattaneo C, Daffini R, Pagani C, Salvetti M, Mancini V, Borlenghi E, D'Adda M, Oberti M, Paini A, De Ciuceis C, Barbullushi K, Cancelli V, Belotti A, Re A, Motta M, Peli A, Bianchetti N, Anastasia A, Dalceggio D, Roccaro AM, Tucci A, Cairoli R, Muiesan ML, Rossi G. Cattaneo C, et al. Among authors: cancelli v. Cancer. 2020 Dec 1;126(23):5069-5076. doi: 10.1002/cncr.33160. Epub 2020 Sep 10. Cancer. 2020. PMID: 32910456 Free article.
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study.
Giorgi-Pierfranceschi M, Paoletti O, Pan A, De Gennaro F, Nardecchia AL, Morandini R, Dellanoce C, Lombi S, Tala M, Cancelli V, Zambelli S, Bosio G, Romanini L, Testa S. Giorgi-Pierfranceschi M, et al. Among authors: cancelli v. Intern Emerg Med. 2020 Nov;15(8):1425-1433. doi: 10.1007/s11739-020-02472-3. Epub 2020 Aug 25. Intern Emerg Med. 2020. PMID: 32840805 Free PMC article.
Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years.
Belotti A, Ribolla R, Cancelli V, Crippa C, Bianchetti N, Ferrari S, Bottelli C, Cattaneo C, Tucci A, De La Fuente Barrigon C, Rossi G. Belotti A, et al. Among authors: cancelli v. Am J Hematol. 2020 Jul;95(7):759-765. doi: 10.1002/ajh.25797. Epub 2020 Apr 23. Am J Hematol. 2020. PMID: 32242970 Free article. Clinical Trial.
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
Malagola M, Polverelli N, Cancelli V, Morello E, Turra A, Borlenghi E, Cattina F, Rambaldi B, Bernardi S, Zanaglio C, Dereli Eke E, Gandolfi L, Farina M, Russo D. Malagola M, et al. Among authors: cancelli v. Case Rep Hematol. 2019 Jun 11;2019:3914828. doi: 10.1155/2019/3914828. eCollection 2019. Case Rep Hematol. 2019. PMID: 31281685 Free PMC article.
Circulating microRNAs and Their Role in Multiple Myeloma.
Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, Ronca R, Chiarini M, Imberti L, Marini M, Rossi G, Presta M, Paiva B, Roccaro AM. Federico C, et al. Among authors: cancelli v. Noncoding RNA. 2019 May 2;5(2):37. doi: 10.3390/ncrna5020037. Noncoding RNA. 2019. PMID: 31052608 Free PMC article. Review.
32 results